• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚微米磷脂分散体分析中的微观方法

Microscopic methods in analysis of submicron phospholipid dispersions.

作者信息

Płaczek Marcin, Kosela Magdalena

出版信息

Acta Pharm. 2016 Mar;66(1):1-22. doi: 10.1515/acph-2016-0003.

DOI:10.1515/acph-2016-0003
PMID:26959541
Abstract

Microscopy belongs to the group of tests, used in pharmaceutical technology, that despite the lapse of time and the development of new analytical methods, still remain irreplaceable for the characterization of dispersed drug dosage forms (e.g., suspensions and emulsions). To obtain complete description of a specific drug formulation, such as parenteral colloidal products, a combination of different microscopic techniques is sometimes required. Electron microscopy methods are the most useful ones; however, even such basic methods as optical microscopy may be helpful for determination of some properties of a sample. The publication explicates the most popular microscopical techniques used nowadays for characterization of the morphology of nanoparticles suspended in pharmaceutical formulations; advantages and disadvantages of these methods are also discussed. Parenteral submicron formulations containing lecithin or a particular phospholipid were chosen as examples.

摘要

显微镜检查属于制药技术中使用的一组测试方法,尽管随着时间的推移和新分析方法的发展,对于表征分散药物剂型(如混悬剂和乳剂)而言,它仍然是不可替代的。为了全面描述特定的药物制剂,如肠胃外胶体产品,有时需要结合不同的显微镜技术。电子显微镜方法是最有用的;然而,即使是光学显微镜这样的基本方法,对于确定样品的某些性质也可能有所帮助。该出版物阐述了目前用于表征药物制剂中悬浮纳米颗粒形态的最常用显微镜技术;还讨论了这些方法的优缺点。以含有卵磷脂或特定磷脂的肠胃外亚微米制剂为例。

相似文献

1
Microscopic methods in analysis of submicron phospholipid dispersions.亚微米磷脂分散体分析中的微观方法
Acta Pharm. 2016 Mar;66(1):1-22. doi: 10.1515/acph-2016-0003.
2
Electron microscopy of pharmaceutical systems.药物系统的电子显微镜观察。
Micron. 2013 Jan;44:45-74. doi: 10.1016/j.micron.2012.07.008. Epub 2012 Aug 8.
3
Comparison of the in vitro cytotoxicity among phospholipid-based parenteral drug delivery systems: Emulsions, liposomes and aqueous lecithin dispersions (WLDs).磷脂类注射用药物递释系统的体外细胞毒性比较:乳剂、脂质体和水性大豆卵磷脂分散体(WLDs)。
Eur J Pharm Sci. 2019 Jan 15;127:92-101. doi: 10.1016/j.ejps.2018.10.018. Epub 2018 Oct 17.
4
Submicron Emulsions and Their Applications in Oral Delivery.亚微米乳剂及其在口服给药中的应用。
Crit Rev Ther Drug Carrier Syst. 2016;33(3):265-308. doi: 10.1615/CritRevTherDrugCarrierSyst.2016017218.
5
Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.纳米化用于口服和肠外药物递送:使用湿磨介质技术对水溶性差的化合物进行制剂的观点。
Adv Drug Deliv Rev. 2011 May 30;63(6):427-40. doi: 10.1016/j.addr.2010.12.007. Epub 2011 Jan 9.
6
Solid Phospholipid Dispersions for Oral Delivery of Poorly Soluble Drugs: Investigation Into Celecoxib Incorporation and Solubility-In Vitro Permeability Enhancement.用于口服难溶性药物的固体磷脂分散体:塞来昔布包合及溶解度-体外渗透增强研究
J Pharm Sci. 2016 Mar;105(3):1113-23. doi: 10.1016/S0022-3549(15)00186-0. Epub 2016 Feb 3.
7
Electron microscopy of nanoemulsions: an essential tool for characterisation and stability assessment.纳米乳剂的电子显微镜观察:特性分析和稳定性评估的重要工具。
Micron. 2012 Feb;43(2-3):85-103. doi: 10.1016/j.micron.2011.07.014. Epub 2011 Jul 29.
8
Overview of drug product development.药品研发概述。
Curr Protoc Pharmacol. 2011 Dec;Chapter 7:Unit 7.3.1-29. doi: 10.1002/0471141755.ph0703s55.
9
SolEmuls-novel technology for the formulation of i.v. emulsions with poorly soluble drugs.
Int J Pharm. 2004 Jan 28;269(2):293-302. doi: 10.1016/j.ijpharm.2003.09.019.
10
Review - An update on the use of oral phospholipid excipients.综述——口服磷脂辅料应用的最新进展
Eur J Pharm Sci. 2017 Oct 15;108:1-12. doi: 10.1016/j.ejps.2017.07.008. Epub 2017 Jul 12.

引用本文的文献

1
Codelivery of Raloxifene and Rutin as PEGylated Nanoliposomes: Formulation, Characterization, and Prophylactic Activity Against Breast Cancer.雷洛昔芬和芦丁作为聚乙二醇化纳米脂质体的共递送:制剂、表征及对乳腺癌的预防活性
Adv Pharm Bull. 2025 Jun 28;15(2):371-389. doi: 10.34172/apb.025.43681. eCollection 2025 Jul.
2
Thermodynamic and Structural Study of Budesonide-Exogenous Lung Surfactant System.布地奈德-外源性肺表面活性剂系统的热力学与结构研究
Int J Mol Sci. 2024 Mar 4;25(5):2990. doi: 10.3390/ijms25052990.
3
Comparative Study of Liposomal and Ethosomal Formulations of Rhizome Extract in a Transdermal Delivery System.
根茎提取物脂质体和醇质体剂型在透皮给药系统中的比较研究
Pharm Nanotechnol. 2025;13(2):303-312. doi: 10.2174/0122117385252518231018161755.
4
Remote loading of curcumin-in-modified β-cyclodextrins into liposomes using a transmembrane pH gradient.利用跨膜pH梯度将姜黄素修饰的β-环糊精远程载入脂质体。
RSC Adv. 2019 Nov 13;9(64):37148-37161. doi: 10.1039/c9ra07560g.
5
Encapsulation of echinomycin in cyclodextrin inclusion complexes into liposomes: anti-proliferative and anti-invasive activity in glioblastoma.将棘霉素包裹于环糊精包合物中再载入脂质体:对胶质母细胞瘤的抗增殖和抗侵袭活性
RSC Adv. 2019 Sep 30;9(53):30976-30988. doi: 10.1039/c9ra05636j. eCollection 2019 Sep 26.
6
Grafting of anti-nucleolin aptamer into preformed and remotely loaded liposomes through aptamer-cholesterol post-insertion.通过适配体-胆固醇后插入法将抗核仁素适配体嫁接到预先形成并远程装载的脂质体中。
RSC Adv. 2020 Oct 1;10(59):36219-36229. doi: 10.1039/d0ra07325c. eCollection 2020 Sep 28.
7
Co-delivery of cisplatin and siRNA through hybrid nanocarrier platform for masking resistance to chemotherapy in lung cancer.通过杂交纳米载体平台共递送顺铂和 siRNA 以掩盖肺癌对化疗的耐药性。
Drug Deliv Transl Res. 2021 Oct;11(5):2052-2071. doi: 10.1007/s13346-020-00867-5. Epub 2020 Nov 11.
8
Development of nanostructured lipid carrier (NLC) assisted with polysorbate nonionic surfactants as a carrier for l-ascorbic acid and Gold Tri.E 30.以聚山梨醇酯非离子表面活性剂为辅助的纳米结构脂质载体(NLC)作为l-抗坏血酸和金三E 30载体的开发。
J Food Sci Technol. 2020 Sep;57(9):3259-3266. doi: 10.1007/s13197-020-04357-x. Epub 2020 Mar 23.
9
c-Myc shuttled by tumour-derived extracellular vesicles promotes lung bronchial cell proliferation through miR-19b and miR-92a.肿瘤衍生细胞外囊泡转运的 c-Myc 通过 miR-19b 和 miR-92a 促进肺支气管细胞增殖。
Cell Death Dis. 2019 Oct 7;10(10):759. doi: 10.1038/s41419-019-2003-5.